Log in to save to my catalogue

New Emerging Biomarkers for Bone Disease: Sclerostin and Dickkopf-1 (DKK1)

New Emerging Biomarkers for Bone Disease: Sclerostin and Dickkopf-1 (DKK1)

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2767356547

New Emerging Biomarkers for Bone Disease: Sclerostin and Dickkopf-1 (DKK1)

About this item

Full title

New Emerging Biomarkers for Bone Disease: Sclerostin and Dickkopf-1 (DKK1)

Publisher

New York: Springer US

Journal title

Calcified tissue international, 2023-02, Vol.112 (2), p.243-257

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

A healthy skeleton depends on a continuous renewal and maintenance of the bone tissue. The process of bone remodeling is highly controlled and consists of a fine-tuned balance between bone formation and bone resorption. Biochemical markers of bone turnover are already in use for monitoring diseases and treatment involving the skeletal system, but n...

Alternative Titles

Full title

New Emerging Biomarkers for Bone Disease: Sclerostin and Dickkopf-1 (DKK1)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2767356547

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2767356547

Other Identifiers

ISSN

1432-0827,0171-967X

E-ISSN

1432-0827

DOI

10.1007/s00223-022-01020-9

How to access this item